GFS Advisors’s Boston Scientific BSX Stock Holding History

GFS Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602	Buy	+60,950	New	+$3.31M	﹤0.01%	262

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GFS Advisors's BSX Position: Q2 2026 in Review

GFS Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 60,950 shares worth $602. The stake represents ﹤0.01% of the portfolio and ranks #262 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

GFS Advisors held 60,950 shares of Boston Scientific worth $602 as of Q2 2026.
Boston Scientific was a new GFS Advisors position in Q2 2026.
Boston Scientific made up ﹤0.01% of GFS Advisors's portfolio in Q2 2026, its #262 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GFS Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.